Kerato Balm 50ml
Fluid balm that reduces the manifestations of nasal and plantar hyperkeratosis.
It improves the hydration of the area and helps to control possible complications of the clinical picture.
Its formulation makes it resistant to water so it lengthens the duration of its effects.
How to use: Apply twice a day for the first 15 days and go to a daily administration 15 days more. After normalization of the area, apply preventively 2-3 times a week.
(*) To pay with PayPal, Contrareembolso and Income/Bank Transfer minimum order will be 49€.
LETIPharma is a bio-pharmaceutical research company, independent and family capital.
In its different areas of expertise, seeks to provide society with products that add value to health care.
Its headquarters are in Barcelona and the industrial plant and the allergy research laboratory are in Tres Cantos (Madrid). It has subsidiaries in Germany (Ismaning and Witten) and in Portugal (Oporto). LETIPharma operates with exclusive distributors in various countries in Europe, Latin America and Africa.
Research and specialization are critical elements in the strategy of LETIPharma. Having innovative and patented products is essential to grow internationally in the chosen market segments. Therefore, LETIPharma has been devoting to research and product development between 10 and 20 percent of its turnover.
Internationalization is an essential element of our strategy. For a specialized company, penetrating foreign markets is a requirement to be able to grow, and this is facilitated by having our own products derived from research. Thus, for LETIPharma, internationalization is both a necessity and an opportunity, as well as being an important enriching element for your organization.
LETIPharma maintains a strategy of close and lasting collaborations with companies in the sector to boost its penetration in foreign markets and to expand its range of products. Also, with universities and research centers, for research and development projects, inside and outside of Spain.
LETIPharma is a founding member of Asebio (Spanish Association of Biocompanies) and of the EAMG (European Allergens Manufacturers Group), is a partner of Farmaindustria, of FENIN (Spanish Federation of Health Technology Companies) and of BPI (Bundesverband der Pharmazeutischen Industrie) and contributes to various organizations and non-profit foundations in areas related to health and education.
Leave us a message